| Tretinoin | Approved Investigational Nutraceutical | DDIT4 | 54541 |
downregulated | Tretinoin results in decreased expression of DDIT4 mRNA | 10q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DDIT4 | 54541 |
upregulated | Tretinoin results in increased expression of DDIT4 mRNA | 10q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DDIT4L | 115265 |
downregulated | Tretinoin results in decreased expression of DDIT4L mRNA | 4q24 | |
| Tretinoin | Approved Investigational Nutraceutical | DDIT4L | 115265 |
upregulated | Tretinoin results in increased expression of DDIT4L mRNA | 4q24 | |
| Tretinoin | Approved Investigational Nutraceutical | DDR1 | 780 |
downregulated | Tretinoin results in decreased expression of DDR1 mRNA | 6p21.33 | |
| Tretinoin | Approved Investigational Nutraceutical | DDR2 | 4921 |
upregulated | Tretinoin results in increased expression of DDR2 mRNA | 1q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | DDT | 1652 |
downregulated | Tretinoin results in decreased expression of DDT mRNA | 22q11.23 | |
| Tretinoin | Approved Investigational Nutraceutical | DDX10 | 1662 |
downregulated | Tretinoin results in decreased expression of DDX10 mRNA | 11q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | DDX17 | 10521 |
downregulated | Tretinoin results in decreased expression of DDX17 mRNA | 22q13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DDX18 | 8886 |
downregulated | Tretinoin results in decreased expression of DDX18 mRNA | 2q14.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DDX21 | 9188 |
downregulated | Tretinoin results in decreased expression of DDX21 mRNA | 10q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DDX25 | 29118 |
downregulated | Tretinoin results in decreased expression of DDX25 mRNA | 11q24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | DDX39A | 10212 |
downregulated | Tretinoin results in decreased expression of DDX39A mRNA | 19p13.12 | |
| Tretinoin | Approved Investigational Nutraceutical | DDX51 | 317781 |
downregulated | Tretinoin results in decreased expression of DDX51 mRNA | 12q24.33 | |
| Tretinoin | Approved Investigational Nutraceutical | DDX58 | 23586 |
upregulated | Tretinoin results in increased expression of DDX58 mRNA | 9p21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DDX59 | 83479 |
downregulated | Tretinoin results in decreased expression of DDX59 mRNA | 1q32.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DEF8 | 54849 |
downregulated | Tretinoin results in decreased expression of DEF8 mRNA | 16q24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | DEFA1 | 1667 |
upregulated | Tretinoin results in increased expression of DEFA1 mRNA | 8p23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DEFA3 | 1668 |
upregulated | Tretinoin results in increased expression of DEFA3 mRNA | 8p23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DEFA4 | 1669 |
upregulated | Tretinoin results in increased expression of DEFA4 mRNA | 8p23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DEGS1 | 8560 |
downregulated | Tretinoin results in decreased expression of DEGS1 mRNA | 1q42.11 | |
| Tretinoin | Approved Investigational Nutraceutical | DEK | 7913 |
downregulated | Tretinoin results in decreased expression of DEK mRNA | 6p22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | DENND1A | 57706 |
downregulated | Tretinoin results in decreased expression of DENND1A mRNA | 9q33.3 | |
| Tretinoin | Approved Investigational Nutraceutical | DENND3 | 22898 |
upregulated | Tretinoin results in increased expression of DENND3 mRNA | 8q24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | DENND5B | 160518 |
upregulated | Tretinoin results in increased expression of DENND5B mRNA | 12p11.21 | |